More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/MediaLibrary/Images/2024-10-17-13-46-20-105-6711152c1028dbec7a3e52c7.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-03-10-09-20-12-342-69afe24c6a34144ee56b3763.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-03-10-09-10-43-763-69afe013e71ee48d195c1a18.jpg)